State of Maine v. Rochelle Gleason

2025 ME 52
CourtSupreme Judicial Court of Maine
DecidedJune 17, 2025
DocketPen-24-248
StatusPublished

This text of 2025 ME 52 (State of Maine v. Rochelle Gleason) is published on Counsel Stack Legal Research, covering Supreme Judicial Court of Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State of Maine v. Rochelle Gleason, 2025 ME 52 (Me. 2025).

Opinion

MAINE SUPREME JUDICIAL COURT Reporter of Decisions Decision: 2025 ME 52 Docket: Pen-24-248 Argued: April 9, 2025 Decided: June 17, 2025

Panel: STANFILL, C.J., and MEAD, HORTON, CONNORS, LAWRENCE, DOUGLAS, and LIPEZ, JJ.

STATE OF MAINE

v.

ROCHELLE GLEASON

MEAD, J.

[¶1] Rochelle Gleason appeals from a judgment of conviction of

aggravated trafficking of a scheduled drug that in fact caused the death of a

person (Class A), 17-A M.R.S § 1105-A(1)(K) (2025), entered by the trial court

(Penobscot County, Mallonee, J.) after a jury trial. On appeal, Gleason raises an

issue concerning her Sixth Amendment right to confront the people who

performed several toxicology tests that served as the basis for an expert

toxicologist’s opinion testimony. The United States Supreme Court’s decision

in Smith v. Arizona, 602 U.S. ---, 144 S. Ct. 1785 (2024), which was issued during

the pendency of this appeal,1 did away with a line of reasoning that the trial

1 The appeal has been pending since May 16, 2024. The Supreme Court issued its decision in Smith v. Arizona, 602 U.S. ---, 144 S. Ct. 1785 (2024), on June 21, 2024. In Griffith v. Kentucky, the Supreme Court held that “a new rule for the conduct of criminal prosecutions is to be applied 2

court relied upon when it admitted the expert toxicologist’s testimony. We

vacate the judgment and remand for a new trial.

I. BACKGROUND

A. Factual Background

[¶2] Viewing the evidence in the light most favorable to its verdict, the

jury rationally could have found the following facts. See State v. Fay, 2015 ME

160, ¶ 2, 130 A.3d 364.

[¶3] In October 2021, Gleason and the decedent communicated regularly

regarding the purchase of fentanyl and heroin, often using slang like “fingy,”

“fetty,” “brown,” and “down.” On October 16, 2021, the decedent messaged

Gleason asking to purchase more drugs. Gleason responded with a voice

message for the decedent, stating that she had some “dark, dark shit that is

expensive but worth it.” She continued that she had acquired some “fire,

harsher shit” and added that she could get him $40 worth. The decedent

agreed.

[¶4] Later that evening, the decedent drove with his twelve-year-old

daughter to Third Street in Bangor. His daughter remained in the car while he

retroactively to all cases, state or federal, pending on direct review or not yet final.” 479 U.S. 314, 328 (1987); accord State v. Labbe, 2024 ME 15, ¶ 39, 314 A.3d 162. Because this case is on direct review, the rule announced in Smith applies retroactively in this case. 3

met with Gleason. His daughter observed the decedent exchange money for

something. The decedent returned home and said goodnight to his daughter.

He then consumed the fentanyl that he had purchased from Gleason, along with

a nonscheduled but potentially lethal fentanyl metabolite called kratom or

mytragynine. The decedent died of acute intoxication shortly after consuming

the drugs.

[¶5] The Maine Office of the Chief Medical Examiner sent a sample of the

decedent’s blood to the NMS Forensic Toxicology Laboratory in Pennsylvania.

At the lab, several lab employees conducted a series of tests on the sample. The

tests included two separate screening tests that screened for a wide variety of

compounds and a confirmatory test to quantify any substance for which the

screening produced positive results. The lab, at the request of the Chief Medical

Examiner, also ran confirmatory tests specifically aimed at determining the

presence and quantity of fentanyl and kratom in the decedent’s blood. Two

different lab employees reviewed the results of the tests to determine whether

the instruments were accurate, there were no anomalies, and appropriate

protocols were being followed. After each test, a lab employee exported the

data from the testing instruments to a computer. A forensic toxicologist who

also works for NMS Laboratory, Chelsea Deisher, then conducted another 4

review of the data and the documentation. Deisher had a record of everyone

who prepared the samples and conducted a review of the data, but she did not

have a record of the employees who had operated the instruments during the

tests or the employees who had exported the data from the instrument to the

computer. Relying upon the results and data obtained by the other employees,

Deisher then developed a toxicology report that revealed that the decedent’s

blood contained 26 nanograms per milliliter of fentanyl, 1.8 nanograms per

milliliter of norfentanyl (a breakdown product of fentanyl), and 22 nanograms

per milliliter of kratom.

B. Procedural History

[¶6] On September 28, 2022, the State charged Gleason by complaint

with aggravated trafficking of a scheduled drug that in fact caused the death of

a person (Class A), 17-A M.R.S. § 1105-A(1)(K). Gleason pleaded not guilty.

[¶7] The court held a five-day trial from April 29 to May 3, 2024. At trial,

Deisher testified for the State about the results of several tests. Deisher

explained that she had not actually conducted the tests but rather had reviewed

the data and documentation and had analyzed the results. Gleason objected to

this testimony and moved for a mistrial on the ground that the testimony

violated her Sixth Amendment Confrontation Clause right because she did not 5

have an opportunity to cross-examine the actual testers to question whether

the test sequences and procedures were properly followed. After hearing

additional testimony outside of the presence of the jury, the court allowed

Deisher to continue testifying.

[¶8] Later, a deputy chief medical examiner testified that the results that

Deisher discussed during her testimony indicated that the decedent had a toxic

level of fentanyl in the blood and died of acute intoxication due to the combined

effects of fentanyl and kratom.

[¶9] The jury returned a verdict of guilty. On May 16, 2024, the court

held a sentencing hearing at which it sentenced Gleason to eighteen years’

imprisonment, with all but eight years suspended, and four years of probation.

[¶10] Gleason timely appealed. See M.R. App. P. 2B(b)(1); 15 M.R.S.

§ 2115 (2025).

II. DISCUSSION

[¶11] The Confrontation Clause of the Sixth Amendment to the United

States Constitution provides that “[i]n all criminal prosecutions, the accused

shall enjoy the right . . . to be confronted with the witnesses against him.” U.S.

Const. amend. VI. The federal Confrontation Clause applies to the states

through the Fourteenth Amendment. Melendez-Diaz v. Massachusetts, 557 U.S. 6

305, 309 (2009); accord State v. Jones, 2018 ME 17, ¶ 8, 178 A.3d 481. “We

review de novo the impact of the admission of testimony on the constitutional

right to confront witnesses.” State v. Judkins, 2024 ME 45, ¶ 11, 319 A.3d 443

(quotation marks omitted).

[¶12] The Confrontation Clause operates by prohibiting the “admission

of testimonial statements of a witness who did not appear at trial unless [that

witness] was unavailable to testify, and the defendant had had a prior

opportunity for cross-examination.” Crawford v. Washington, 541 U.S. 36,

53-54 (2004).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State of Maine v. Kenneth Rhoades
2026 ME 23 (Supreme Judicial Court of Maine, 2026)

Cite This Page — Counsel Stack

Bluebook (online)
2025 ME 52, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-of-maine-v-rochelle-gleason-me-2025.